Ubs Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 17-12-2024
- Revenue -80.53%
(FY 2022)
- Profit -4634.59%
(FY 2022)
- Ebitda -76.15%
(FY 2022)
- Net Worth -114.93%
(FY 2022)
- Total Assets -37.25%
(FY 2022)
About Ubs Healthcare
The Corporate was formerly known as Glumex Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Apurva Shah, Rushab Patel, Kashmal Mehta, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191MH2012PTC226862
- Company No.
226862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ubs Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushab Patel  | Director | 14-Sep-2017 | Current |
| Ravindra Sathe | Director | 13-Feb-2012 | Current |
| Apurva Shah | Director | 13-Feb-2012 | Current |
| Kashmal Mehta | Director | 13-Feb-2012 | Current |
Financial of Ubs Healthcare.
Ubs Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 80.53% decrease. The company also saw a substantial fall in profitability, with a 4634.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ubs Healthcare?
In 2019, Ubs Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glumex Pharmaceuticals Manufacturing Pvt Ltd.Active 35 years 5 monthsApurva Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 10 Aug 2017 | ₹5.00 M | Open |
How Many Employees Work at Ubs Healthcare?
Unlock and access historical data on people associated with Ubs Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ubs Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubs Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
